UBS starts Axsome at buy, sees Auvelity hitting $1B sales by 2030
https://seekingalpha.com/news/4064942-ubs-starts-axsome-at-buy-sees-auvelity-hitting-1b-sales-by-2030?source=feed_sector_healthcare
Feb 08, 2024 - UBS has initiated coverage of Axsome Therapeutics (AXSM) with a buy rating, commenting that it was bullish on the launch of the company’s drug Auvelity and upco
0
Nvidia: UBS Note Should Raise Alarms
https://seekingalpha.com/article/4670524-nvidia-ubs-note-should-raise-alarms?source=feed
Feb 15, 2024 - UBS raises Nvidia's (NVDA) earnings estimates and price target, but warns of near-term trouble for growth due to decreased lead times. Learn why it is posing a risk for investors.
0
Alkermes downgraded at UBS as stock nears 52-week high
https://seekingalpha.com/news/4069051-alkermes-downgraded-ubs-stock-nears-52-week-high?source=feed_sector_healthcare
Feb 20, 2024 - UBS downgrades Alkermes to sell due to disappointing sales and negative pipeline update. Read more here.
0
Global Stock leaders for 2030 in Health Tech - UBS
https://seekingalpha.com/news/4088685-global-stock-leaders-for-2030-in-health-tech-ubs?source=feed_sector_healthcare
Apr 10, 2024 - UBS spotlighted global companies in healthcare tech that are poised for growth.
0
'Lose-lose situation': New Swiss bank laws could derail UBS' challenge to Wall Street giants
https://www.cnbc.com/2024/04/11/lose-lose-situation-new-swiss-bank-laws-could-derail-ubs-challenge-to-wall-street-giants.html
Apr 11, 2024 - Switzerland's new banking regulations create a "lose-lose situation" for UBS and may limit its potential to challenge Wall Street, says Beat Wittmann of Porta Advisors.
0
We're not headed for another global financial crisis, top UBS economist says after recession warning
https://www.cnbc.com/2023/11/15/next-global-financial-crisis-is-not-ahead-ubs-us-chief-economist.html
Nov 15, 2023 - Credit tightening in the U.S. has raised concerns about the state of the economy and what could happen next.
0
UBS (UBS) Up 12.3% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2194950/ubs-ubs-up-12-3-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2194950
Dec 07, 2023 - UBS (UBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
UBS and Credit Suisse Agree to Merge Their Parent Banks
https://www.zacks.com/stock/news/2196038/ubs-and-credit-suisse-agree-to-merge-their-parent-banks?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2196038
Dec 11, 2023 - UBS Group AG (UBS) and Credit Suisse approve the merger between their parent banks, which is expected to be completed in 2024.
0
UBS Group AG (UBS) Aided by Strategic Buyouts Amid High Costs
https://www.zacks.com/stock/news/2232509/ubs-group-ag-ubs-aided-by-strategic-buyouts-amid-high-costs?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2232509
Feb 27, 2024 - Business restructuring plans and strategic acquisitions support UBS Group AG's (UBS) financials. However, rising costs will likely limit bottom-line growth.
0
UBS (UBS) Up 5% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2237436/ubs-ubs-up-5-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2237436
Mar 07, 2024 - UBS (UBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0